FDA Investigator Christopher B May

Christopher B May has inspections in 11 countries as of 15 Sep 2023. Christopher B May has collaborated with a combinined 1900 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
78
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Switzerland, Belgium, Italy, Germany, Sweden, Japan, United Kingdom of Great Britain and Northern Ireland, Romania, Netherlands
Co-Investigator(s):
A Williams, Abraham M Maekele, Adaliz Santaliz Cruz, Aigbokhai A Dirisu, Alice S Tsao, Andrew Saunders, Babatunde D Babalola, Benjamin J Dastoli, Betsy C Galliher, Brenda Rivera, Burnell M Henry, Catherine J Laufmann, Charles M Kerns, BLT DO, Chateryl K Washington, Cherry R Valerio, Christie B Rice, Christine M O'leary, Christopher C Wilcox, Claudette D Brooks, Cynthia Jim, CSO, David E Lowe, David P Vanhouten, Dawn M Braswell, Delkis J Caycedo, Dellarese L Herbert, Demario L Walls, Derek C Price, Devaughn Edwards, Don A Leeseberg, Dr. Jason R Caballero, Edward Deberry, Edward E Lockwood (EEL), Edward E, Lockwood, Eliezar Ramos, Emma R Schaefer, Ernest H Blackwood, Gamal A Norton, George T Allen, Jr, Harperd, Heather Akleimola Hulbert, Heather M Wheeler, Ibad U Khan, Inga M Warr, Iram R Hassan, PhD, Jacqueline Mdiaz Albertini, Jennifer L Bridgewater, Jessica A Stephens, Joe A Odom, John A Casanova, John M Gusto, Joshua J Silvestri, Julie D Bringger, Kara D Miller, Karen A Coleman, Kimberly Lewandowski Walker, Laiza V Garcia, Laureen M Geniusz, Leo J Lagrotte, Lori S Lawless, M Patriciaurphy Murphy, Marc A Alston, Marissa S Steinhagen, Mark E Chan, Mary L Schuckmann, Matthew A Humbard, Matthew A, Humbard, Melanie G Warzala, Melanie W Pishnery, Miaja Umaedi, Michael C Ireland, Michael G Mayfield, Michelle D Haamid, Mihaly S Ligmond, Myoshi M Francis, Nikki S Bryant, Noreen Muniz, Paul A Bonneau, Paul A Licata, Paul W Moy, Penny H Mccarver, Perry H Gambrell, Prabhu P Raju, R Edwadebey Deberry, Randy L Clarida, Richard K Vogel, Richard L Rutherford, Richard W Thornton, Saeid E Kazan, Samuel L Murray, Sarah A Hassas, Sarah Forney, Sayeeda Hdabe, Seneca D Toms, State Agency, Stephen D Brown, Stephen D Eich, Steven J Thurber, Tammara A Newberry, Tammara A Stephens, Tania E Vizcaino, Teresa Jimenez, Terri L Jones, Terry C Kimball, Thomas D Clarida, Trang N Cox, Wanda J Torres

Christopher B May's Documents

Publish Date Document Type Title
March, 2018 FDA 483 Response Carolina Biological Supply Co - Form 483R, 2018-06-08
February, 2022 FDA 483 MRI CARDIAC SERVICES INCORPORATED - Form 483, 2022-02-24
July, 2016 FDA 483 Avanos Medical, Inc. - Form 483, 2016-07-29
April, 2022 FDA 483 American Contract Systems, Inc. - Form 483, 2022-04-08
July, 2018 FDA 483 ScandiDos AB - Form 483, 2018-07-12
November, 2022 FDA 483 Greer Laboratories, Inc. - Form 483, 2022-11-01
November, 2015 FDA 483 Contec Inc- Sporicidin Division - Form 483, 2015-11-13
October, 2019 FDA 483 Monitor Instruments, Inc. - Form 483, 2019-10-10
June, 2018 FDA 483 Bright Enterprises, Inc - Form 483, 2018-06-18
March, 2018 FDA 483 Carolina Biological Supply Co - Form 483, 2018-03-08
November, 2015 FDA 483 Medical Specialties Inc - Form 483, 2015-11-09
December, 2021 FDA 483 Surgical Technology Laboratories, Inc - Form 483, 2021-12-10
September, 2022 FDA 483 Carolina Biological Supply Co - Form 483, 2022-09-23
March, 2023 FDA 483 WEG Surgical Solutions - Form 483, 2023-03-08
March, 2018 EIR Carolina Biological Supply Co - EIR, 2018-03-08
January, 2017 FDA 483 Tripath Imaging, Inc. - Form 483, 2017-01-10
July, 2021 FDA 483 FPE NC LLC - Form 483, 2021-07-23
July, 2019 FDA 483 Medfaxx, Inc. - Form 483, 2019-07-10
December, 2017 EIR Charter Medical Limited - EIR, 2017-12-11
June, 2023 FDA 483 Carolon Company - Form 483, 2023-06-15
October, 2018 FDA 483 O. R. Surgical Company Inc. - Form 483, 2018-10-12
December, 2017 FDA 483 Response Charter Medical Limited - Form 483R, 2018-01-04
December, 2023 FDA 483 Tex-Care Medical - Form 483, 2023-12-15

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more